These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 36069578

  • 21. An updated patent review of metallo-β-lactamase inhibitors (2020-2023).
    Denakpo E, Naas T, Iorga BI.
    Expert Opin Ther Pat; 2023; 33(7-8):523-538. PubMed ID: 37737836
    [Abstract] [Full Text] [Related]

  • 22. Virtual screening identifies broad-spectrum β-lactamase inhibitors with activity on clinically relevant serine- and metallo-carbapenemases.
    Spyrakis F, Santucci M, Maso L, Cross S, Gianquinto E, Sannio F, Verdirosa F, De Luca F, Docquier JD, Cendron L, Tondi D, Venturelli A, Cruciani G, Costi MP.
    Sci Rep; 2020 Jul 29; 10(1):12763. PubMed ID: 32728062
    [Abstract] [Full Text] [Related]

  • 23. Potential inhibitors designed against NDM-1 type metallo-β-lactamases: an attempt to enhance efficacies of antibiotics against multi-drug-resistant bacteria.
    Khan AU, Ali A, Danishuddin, Srivastava G, Sharma A.
    Sci Rep; 2017 Aug 23; 7(1):9207. PubMed ID: 28835636
    [Abstract] [Full Text] [Related]

  • 24. A close look onto structural models and primary ligands of metallo-β-lactamases.
    Raczynska JE, Shabalin IG, Minor W, Wlodawer A, Jaskolski M.
    Drug Resist Updat; 2018 Sep 23; 40():1-12. PubMed ID: 30466711
    [Abstract] [Full Text] [Related]

  • 25. N-Aryl Mercaptopropionamides as Broad-Spectrum Inhibitors of Metallo-β-Lactamases.
    Kaya C, Konstantinović J, Kany AM, Andreas A, Kramer JS, Brunst S, Weizel L, Rotter MJ, Frank D, Yahiaoui S, Müller R, Hartmann RW, Haupenthal J, Proschak E, Wichelhaus TA, Hirsch AKH.
    J Med Chem; 2022 Mar 10; 65(5):3913-3922. PubMed ID: 35188771
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Targeting clinically-relevant metallo-β-lactamases: from high-throughput docking to broad-spectrum inhibitors.
    Brindisi M, Brogi S, Giovani S, Gemma S, Lamponi S, De Luca F, Novellino E, Campiani G, Docquier JD, Butini S.
    J Enzyme Inhib Med Chem; 2016 Mar 10; 31(sup1):98-109. PubMed ID: 27121013
    [Abstract] [Full Text] [Related]

  • 29. The Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 Restores the Potency of Multiple Oral Beta-Lactam Antibiotics against Beta-Lactamase-Producing Strains of Resistant Enterobacterales.
    Lomovskaya O, Rubio-Aparicio D, Tsivkovski R, Loutit J, Dudley M.
    Antimicrob Agents Chemother; 2022 Feb 15; 66(2):e0216821. PubMed ID: 34902261
    [Abstract] [Full Text] [Related]

  • 30. 3-O-Substituted Quercetin: an Antibiotic-Potentiating Agent against Multidrug-Resistant Gram-Negative Enterobacteriaceae through Simultaneous Inhibition of Efflux Pump and Broad-Spectrum Carbapenemases.
    Lee T, Lee S, Kim MK, Ahn JH, Park JS, Seo HW, Park KH, Chong Y.
    ACS Infect Dis; 2024 May 10; 10(5):1624-1643. PubMed ID: 38652574
    [Abstract] [Full Text] [Related]

  • 31. In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant Enterobacterales.
    Peters BK, Reddy N, Shungube M, Girdhari L, Baijnath S, Mdanda S, Chetty L, Ntombela T, Arumugam T, Bester LA, Singh SD, Chuturgoon A, Arvidsson PI, Maguire GEM, Kruger HG, Naicker T, Govender T.
    ACS Infect Dis; 2023 Mar 10; 9(3):486-496. PubMed ID: 36786013
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Beta-lactamase inhibitors: the story so far.
    Pérez-Llarena FJ, Bou G.
    Curr Med Chem; 2009 Mar 10; 16(28):3740-65. PubMed ID: 19747143
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
    Wachino JI, Jin W, Kimura K, Kurosaki H, Sato A, Arakawa Y.
    mBio; 2020 Mar 17; 11(2):. PubMed ID: 32184250
    [Abstract] [Full Text] [Related]

  • 40. High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1.
    Rehman MT, AlAjmi MF, Hussain A, Rather GM, Khan MA.
    Int J Mol Sci; 2019 Feb 14; 20(4):. PubMed ID: 30769822
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.